Updated: February 5, 2026
Astagraf XL Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Is Astagraf XL in a shortage in 2026? Here's the latest on tacrolimus extended-release availability, what has caused past supply problems, and how patients can protect their supply.
Tacrolimus has had a complicated shortage history in the United States, and kidney transplant patients who depend on Astagraf XL (tacrolimus extended-release capsules) have legitimate reasons to stay informed about availability. This article provides the latest 2026 update on Astagraf XL supply, the history of tacrolimus shortages, and what you can do to protect your medication access.
Astagraf XL Shortage Status in 2026
As of 2026, Astagraf XL is not listed on an active nationwide FDA drug shortage. The American Society of Health-System Pharmacists (ASHP) has confirmed that Astellas Pharma has Astagraf XL capsules available in all three strengths: 0.5 mg, 1 mg, and 5 mg (30-count bottles).
However, not in a formal shortage does not mean universally easy to find. Patients continue to report localized stocking issues at retail pharmacies, particularly because Astagraf XL is:
- A brand-only medication with no commercially available generic
- Primarily distributed through specialty pharmacy channels
- Not regularly stocked at all retail pharmacy locations
The History of Tacrolimus Shortages in the United States
The broader tacrolimus class has experienced significant shortage events. Generic tacrolimus immediate-release capsules have had multiple shortage periods, driven by raw ingredient supply issues, manufacturing delays, and allocation problems. During the 2019 shortage, the American Society of Transplantation and Transplant Pharmacy communities issued formal guidance recommending that patients unable to obtain generic tacrolimus IR consider switching to branded formulations like Prograf or Astagraf XL -- under physician supervision.
Astagraf XL itself has historically not been the formulation on shortage -- it was actually recommended as an alternative during generic tacrolimus IR shortages. The challenge for Astagraf XL patients is more about limited distribution than active shortage.
Why Do Tacrolimus Formulation Shortages Happen?
Several systemic factors contribute to tacrolimus availability challenges:
- Raw ingredient shortages: Tacrolimus requires complex synthesis, and raw material supply disruptions can cascade into manufacturing delays
- Concentrated manufacturer base: A handful of manufacturers produce the majority of tacrolimus; when one has issues, others may not be able to fill the gap quickly
- Non-interchangeability rules: Tacrolimus formulations (IR, Astagraf XL, Envarsus XR) are not interchangeable, fragmenting demand and making substitution difficult
- Just-in-time pharmacy inventory: Pharmacies maintain minimal buffer stock, leaving little cushion when supply hiccups occur
What Kidney Transplant Patients Should Watch For
Even when no formal shortage exists, be alert for these warning signs that your supply may be at risk:
- Your regular pharmacy says they are out of stock or have limited supply
- Multiple pharmacies in your area are unable to fill the prescription
- Your transplant team or pharmacist mentions supply concerns
- ASHP or FDA issues a new shortage alert for tacrolimus extended-release formulations
How to Protect Your Astagraf XL Supply
The most reliable protection against supply disruptions is proactive management:
- Always refill 7-10 days early. Never wait until you have 1-2 days of medication left.
- Use a specialty pharmacy. Transplant specialty pharmacies stock Astagraf XL more reliably than general retail chains.
- Consider mail-order pharmacy for 90-day supply. A larger supply buffer reduces risk.
- Use medfinder if your pharmacy is out. medfinder calls pharmacies near you to find which ones have Astagraf XL in stock.
- Keep your transplant team informed. They need to know about supply problems early -- not after you've already missed doses.
Bottom Line for 2026
Astagraf XL is not in an active nationwide shortage in 2026, but localized stocking gaps are real and the medication requires proactive management. Stay ahead of your refill, use specialty pharmacies, and have a plan. For more details, see why Astagraf XL is hard to find and alternatives to Astagraf XL if needed.
Frequently Asked Questions
As of 2026, Astagraf XL is not on the FDA's active drug shortage list and Astellas has confirmed supply availability. However, individual pharmacies may experience localized stocking gaps, particularly retail pharmacies that don't specialize in transplant medications.
Yes -- generic tacrolimus immediate-release capsules have experienced multiple shortage periods in the United States, notably in 2019. These shortages were driven by raw ingredient issues and manufacturing disruptions. During these events, Astagraf XL was recommended as an alternative formulation to keep patients stable while under physician supervision.
The FDA's drug shortage database (accessdata.fda.gov) and ASHP's drug shortage list (ashp.org) are the most authoritative sources for shortage information. Astagraf XL-specific updates would appear under tacrolimus extended-release capsules. Always check with your transplant team and pharmacist for the most current local availability information.
Past tacrolimus shortages were caused by raw ingredient supply disruptions, manufacturing delays, and concentrated production among a small number of manufacturers. When one manufacturer faced issues, others could not quickly absorb the additional demand. The non-interchangeability between tacrolimus formulations also fragmented supply, making specific versions harder to find.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Astagraf XL also looked for:
More about Astagraf XL
35,181 have already found their meds with Medfinder.
Start your search today.





